Invrix.com
Analysis Tools
Financial Statement Analysis
Industry Analysis
News Analysis
User
Login
Register
Analysis Tools
Financial Trends
Company Comparisons
Profitability Radar
Industry Leaderboard
User
Login
Register
Home
/
Biotechnology: Pharmaceutical Preparations
/
HROWL
Harrow 8.625% Senior Notes Due 2026(Hrowl) Financials: Compared To Industry Average, Plus Other Key Ratios
Report
Profitability
Growth
Liquidity
Solvency
Valuation
Company Report for HROWL
